Monday 24 January 2011

Repronex injectable


Generic Name: menotropins (injectable) (MEN oh troe pins)

Brand Names: Menopur, Repronex


What are menotropins?

Menotropins are an equal mixture of the naturally occurring follicle-stimulating hormone (FSH) and luteinizing hormone (LH). FSH and LH are important for the development of follicles (eggs) produced by the ovaries and for the development of sperm.


Menotropins are used to stimulate ovulation (the release of an egg) when a woman's ovaries can produce a follicle but hormonal stimulation is deficient. Menotropins are also used to stimulate the development of multiple eggs for in vitro fertilization. Likewise, menotropins are used to stimulate the production of sperm in men who have functioning testes but in whom hormonal stimulation is deficient.


Menotropins may also be used for purposes other than those listed in this medication guide.


What is the most important information I should know about menotropins?


Menotropins may increase the likelihood of multiple births. Multiple births may carry additional risk both for the mother and for the fetuses.


What should I discuss with my healthcare provider before using menotropins?


Menotropins will not induce ovulation or sperm production if your ovaries or testes are not functioning properly.


Do not use menotropins without first taking to your doctor if you

  • might be pregnant;




  • have a thyroid problem;




  • have cancer or a tumor of the breast, ovary, uterus, hypothalamus, or pituitary gland;




  • have undiagnosed vaginal bleeding;




  • have ovarian cysts or enlargement; or




  • have any other serious or chronic medical illness.



You may not be able to use menotropins, or you may require a dosage adjustment or special monitoring if you have any of the conditions listed above.


Do not use menotropins if you are pregnant. Menotropins are in the FDA pregnancy category X. This means that they are known to cause birth defects. It is not known whether menotropins pass into breast milk. Do not use menotropins without first talking to your doctor if you are breast-feeding a baby.

How should I use menotropins?


Use menotropins exactly as directed by your doctor. If you do not understand these directions, ask your doctor, nurse, or pharmacist to explain them to you.


Formulations of menotropins intended for intramuscular injection (an injection into muscle) must not be administered subcutaneously (under the skin), and vice versa. If you are administering this medication at home, your doctor will give you detailed instructions on how to mix the solution and give yourself the injection. Do not inject menotropins if you are not sure how.


Use the solution immediately after it is mixed. Throw away any medicine that is left over.


Never reuse a needle or syringe. Dispose of all needles and syringes in an appropriate, puncture-resistant disposal container.


Store menotropins at room temperature or in the refrigerator, away from direct light, moisture, and heat.


What happens if I miss a dose?


Contact your doctor if you miss a dose of menotropins. Do not use a double dose of this medication without first talking to your doctor.


What happens if I overdose?


An overdose of menotropins is unlikely to threaten life. Notify your doctor immediately or call an emergency room or poison control center for advice.

Symptoms of a menotropins overdose are not known. Ovarian hyperstimulation syndrome (OHSS) may result with an overdose of menotropins. Symptoms of OHSS include swelling of the hands or legs, abdominal pain and swelling, shortness of breath, weight gain, and nausea or vomiting. OHSS can be fatal.


What should I avoid while using menotropins?


There are no restrictions on food, beverages, or activity during therapy with menotropins unless your doctor directs otherwise.


Menotropins side effects


Stop using menotropins and seek emergency medical attention if you experience an allergic reaction (difficulty breathing; closing of your throat; swelling of your lips, tongue, or face; or hives).

Less than 2% of female patients treated with menotropins develop ovarian hyperstimulation syndrome (OHSS), especially after the first cycle of therapy. Symptoms of OHSS include swelling of the hands or legs, abdominal pain and swelling, shortness of breath, weight gain, and nausea or vomiting. OHSS can be fatal. Notify your doctor immediately or seek emergency medical attention if you develop any of these side effects.


Serious pulmonary (lung and breathing) conditions have been reported in patients using menotropins. Seek medical attention if you experience any sudden changes in your breathing.


Other side effects may also occur. Notify your doctor if you experience



  • ovarian enlargement presenting as abdominal or pelvic pain, tenderness, pressure, or swelling;




  • nausea, vomiting, or diarrhea;




  • shortness of breath;




  • pain, warmth, or tenderness centralized in an arm or leg;




  • fever or chills;




  • headache or drowsiness;




  • weakness or aching of muscles or joints;




  • breast enlargement or tenderness;




  • pain, swelling, or irritation at the injection site; or




  • rash.



Menotropins may increase the likelihood of multiple births. Multiple births may carry additional risk both for the mother and for the fetuses.


This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect menotropins?


It is not known whether other medications will interact with menotropins. Talk to your doctor and pharmacist before taking any prescription or over-the-counter medicines including vitamins, minerals, and herbal products.



More Repronex resources


  • Repronex Side Effects (in more detail)
  • Repronex Use in Pregnancy & Breastfeeding
  • Repronex Drug Interactions
  • Repronex Support Group
  • 0 Reviews for Repronex - Add your own review/rating


Compare Repronex with other medications


  • Female Infertility
  • Follicle Stimulation
  • Ovulation Induction


Where can I get more information?


  • Your pharmacist can provide more information about menotropins.

See also: Repronex side effects (in more detail)


Saturday 22 January 2011

Risatarun




Risatarun may be available in the countries listed below.


Ingredient matches for Risatarun



Deanol

Deanol aceglumate (a derivative of Deanol) is reported as an ingredient of Risatarun in the following countries:


  • Germany

International Drug Name Search

Thursday 20 January 2011

Xipamid-CT




Xipamid-CT may be available in the countries listed below.


Ingredient matches for Xipamid-CT



Xipamide

Xipamide is reported as an ingredient of Xipamid-CT in the following countries:


  • Germany

International Drug Name Search

Monday 17 January 2011

Atropina Solfato Salf




Atropina Solfato Salf may be available in the countries listed below.


Ingredient matches for Atropina Solfato Salf



Atropine

Atropine sulfate (a derivative of Atropine) is reported as an ingredient of Atropina Solfato Salf in the following countries:


  • Italy

International Drug Name Search

Wednesday 12 January 2011

Eprosartan




In the US, Eprosartan (eprosartan systemic) is a member of the drug class angiotensin II inhibitors and is used to treat High Blood Pressure.

US matches:

  • Eprosartan

  • Eprosartan/Hydrochlorothiazide

  • Eprosartan Mesylate

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C09CA02

CAS registry number (Chemical Abstracts Service)

0133040-01-4

Chemical Formula

C23-H24-N2-O4-S

Molecular Weight

424

Therapeutic Categories

Antihypertensive agent

Angiotensin-II antagonist

Chemical Name

2-Thiophenepropanoic acid, α-[[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-, (E)-

Foreign Names

  • Eprosartanum (Latin)
  • Eprosartan (German)
  • Éprosartan (French)
  • Eprosartan (Spanish)

Generic Names

  • Eprosartan (OS: USAN, BAN)
  • Éprosartan (OS: DCF)
  • SKF 108566 (IS: SmithKlineBeec)
  • Eprosartan Mesilate (OS: BANM)
  • Eprosartan Mesylate (OS: USAN)
  • SKF 108566-J (IS: SmithKlineBeec)

Brand Names

  • CoTeveten (Eprosartan and Hydrochlorothiazide)
    Solvay, Slovenia


  • Teveten
    Solvay, Latvia; Solvay, Romania; Solvay, Tunisia; Solvay, Turkey; Solvay, Taiwan


  • Teveten plus (Eprosartan and Hydrochlorothiazide)
    Solvay, Turkey


  • Coepratenz Plus (Eprosartan and Hydrochlorothiazide)
    Solvay, Austria; Solvay, Poland


  • CoTeveten (Eprosartan and Hydrochlorothiazide)
    Solvay, France


  • Emestar
    Trommsdorff, Germany


  • Emestar plus (Eprosartan and Hydrochlorothiazide)
    Trommsdorff, Germany


  • Epratenz
    Famar, Greece


  • Epratenz (Eprosartan and Hydrochlorothiazide)
    Famar, Greece


  • Epratenzide Plus (Eprosartan and Hydrochlorothiazide)
    Solvay, Germany


  • Eprosartan Hydrochlorothiazide Tora (Eprosartan and Hydrochlorothiazide)
    Tora, Spain


  • Eprosartan-CT
    CT Arzneimittel, Germany


  • Eprosartan-ratiopharm
    Ratiopharm, Germany


  • Eprosartan-ratiopharm comp. (Eprosartan and Hydrochlorothiazide)
    Ratiopharm, Germany


  • Eprotan-Mepha
    Mepha Pharma, Switzerland


  • Eprotan-Mepha (Eprosartan and Hydrochlorothiazide)
    Mepha Pharma, Switzerland


  • Futuran Plus (Eprosartan and Hydrochlorothiazide)
    Merck, Spain


  • Futuran
    Merck, Spain


  • Navixen Plus (Eprosartan and Hydrochlorothiazide)
    Ferrer, Spain


  • Navixen
    Ferrer, Spain


  • Regulaten Plus (Eprosartan and Hydrochlorothiazide)
    Juste, Spain


  • Regulaten
    Juste, Spain


  • Tevetec HCT (Eprosartan and Hydrochlorothiazide)
    Solvay, Poland


  • Teveten HCT (Eprosartan and Hydrochlorothiazide)
    Abbott, United States; Kos, United States


  • Teveten Plus (Eprosartan and Hydrochlorothiazide)
    Dr. Fisher, Netherlands; Euro, Netherlands; Medcor, Netherlands; Solvay, Australia; Solvay, Belgium; Solvay, Canada; Solvay, Germany; Solvay, Netherlands; Solvay, South Africa


  • Teveten
    Abbott, United States; Dr. Fisher, Netherlands; Euro, Netherlands; Kos, United States; Medcor, Netherlands; Orion, Finland; Solvay, Austria; Solvay, Australia; Solvay, Belgium; Solvay, Bulgaria; Solvay, Bulgaria; Solvay, Bulgaria; Solvay, Canada; Solvay, Czech Republic; Solvay, Germany; Solvay, Denmark; Solvay, Estonia; Solvay, France; Solvay, United Kingdom; Solvay, Georgia; Solvay, Georgia; Solvay, Greece; Solvay, Hong Kong; Solvay, Croatia (Hrvatska); Solvay, Indonesia; Solvay, Ireland; Solvay, Iceland; Solvay, Lithuania; Solvay, Luxembourg; Solvay, Malta; Solvay, Netherlands; Solvay, Norway; Solvay, Oman; Solvay, Philippines; Solvay, Poland; Solvay, Portugal; Solvay, Russian Federation; Solvay, Sweden; Solvay, Singapore; Solvay, Thailand; Solvay, South Africa; Solvay Pharma, Switzerland


  • Teveten Comp. (Eprosartan and Hydrochlorothiazide)
    Solvay, Denmark; Solvay, Norway; Solvay, Sweden


  • Teveten plus (Eprosartan and Hydrochlorothiazide)
    Solvay, Austria; Solvay, Croatia (Hrvatska); Solvay, Ireland; Solvay, Malta; Solvay, Slovakia; Solvay Pharma, Switzerland


  • Tevetens Plus (Eprosartan and Hydrochlorothiazide)
    Solvay, Spain


  • Tevetens
    Solvay, Spain


  • Tevetenz Orifarm
    Solvay, Denmark


  • Tevetenz Paranova
    Solvay, Denmark


  • Tevetenz
    Italmex, Mexico; Solvay, Italy

International Drug Name Search

Glossary

BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Monday 10 January 2011

Renidon




Renidon may be available in the countries listed below.


Ingredient matches for Renidon



Ibuprofen

Ibuprofen is reported as an ingredient of Renidon in the following countries:


  • Philippines

International Drug Name Search

Anzemet


Anzemet is a brand name of dolasetron, approved by the FDA in the following formulation(s):


ANZEMET (dolasetron mesylate - injectable; injection)



  • Manufacturer: SANOFI AVENTIS US

    Approval date: September 11, 1997

    Strength(s): 100MG/5ML (20MG/ML) [RLD], 12.5MG/0.625ML (20MG/ML) [RLD]


  • Manufacturer: SANOFI AVENTIS US

    Approval date: December 11, 2001

    Strength(s): 500MG/25ML (20MG/ML) [RLD]

ANZEMET (dolasetron mesylate - tablet; oral)



  • Manufacturer: SANOFI AVENTIS US

    Approval date: September 11, 1997

    Strength(s): 100MG [RLD], 50MG

Has a generic version of Anzemet been approved?


No. There is currently no therapeutically equivalent version of Anzemet available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Anzemet. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3-(4H)-one and related compounds
    Patent 4,906,755
    Issued: March 6, 1990
    Inventor(s): Gittos; Maurice W.
    Assignee(s): Merrell Dow Pharmaceuticals Inc.
    The present invention is directed to a group of esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(3H)-ones and related compounds. The compounds are prepared from the appropriate carboxylic acids and alcohols by standard procedures or, where steric factors are significant, a new process which makes use of heavy metal salts of super acids can be used. The compounds involved are useful in the treatment of migraine and similar disorders and in cytotoxic drug-induced vomiting.
    Patent expiration dates:

    • July 2, 2011



See also...

  • Anzemet Consumer Information (Drugs.com)
  • Anzemet Consumer Information (Wolters Kluwer)
  • Anzemet Tablets Consumer Information (Wolters Kluwer)
  • Anzemet Consumer Information (Cerner Multum)
  • Anzemet Advanced Consumer Information (Micromedex)
  • Anzemet AHFS DI Monographs (ASHP)
  • Dolasetron Consumer Information (Wolters Kluwer)
  • Dolasetron Tablets Consumer Information (Wolters Kluwer)
  • Dolasetron Consumer Information (Cerner Multum)
  • Dolasetron injection Consumer Information (Cerner Multum)
  • Dolasetron Oral, Intravenous Advanced Consumer Information (Micromedex)
  • Dolasetron Mesylate AHFS DI Monographs (ASHP)

Sunday 9 January 2011

Salzone




Salzone may be available in the countries listed below.


Ingredient matches for Salzone



Paracetamol

Paracetamol is reported as an ingredient of Salzone in the following countries:


  • Ghana

  • Kenya

  • Nigeria

  • Sudan

International Drug Name Search

Oxytocin Ferring-Leciva




Oxytocin Ferring-Leciva may be available in the countries listed below.


Ingredient matches for Oxytocin Ferring-Leciva



Oxytocin

Oxytocin is reported as an ingredient of Oxytocin Ferring-Leciva in the following countries:


  • Czech Republic

  • Slovakia

International Drug Name Search